跳至主要内容
临床试验/CTRI/2024/09/074468
CTRI/2024/09/074468尚未招募4 期

Effect of granulocyte colony stimulating factor (G-CSF) in prevention of radiation induced oral mucositis in patients receiving chemo-radiotherapy for head and neck cancer.

VMMC and Safdarjung hospital1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2024年10月22日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
70
试验地点
1
主要终点
To ascertain the efficacy of granulocyte-colony stimulating factor (G-CSF) by

研究概览

简要总结

It is an interventional study. Patients will have to give detailed clinical history and undergo clinical examination with evaluation of the primary tumour, nodes and metastasis. Radiation dose will be 66-70 Gy as total dose, with 2Gy in each fraction given over 5 consecutive days. Chemotherapy will be given as weekly intravenous cisplatin (40mg/m2) as per standard protocol. Patients who have received radiation dose of 10 Gy, will be administered 2µg/kg/day subcutaneously of granulocyte-colony stimulating factor (G-CSF) in the unirradiated normal skin daily till the end of radiation therapy. Patients will be assessed with daily clinical examination, to grade oral mucositis using RTOG criteria(8), and weekly blood tests.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients having age more than 18 years, and are histologically proven case of squamous cell carcinoma of head and neck with ECOG performance status of 0-
  • Patients who have received a radiation dose of 10Gy to head and neck area during current chemo-radiotherapy treatment.

排除标准

  • Patients with recurrent or metastatic disease or second primary.
  • Prior irradiation to head and neck area.
  • History of anaphylaxis to G-CSF injection.

结局指标

主要结局

To ascertain the efficacy of granulocyte-colony stimulating factor (G-CSF) by

时间窗: weekly during the course of radiation therapy

studying the incidence of grade III/IV oral mucositis, using RTOG criteria

时间窗: weekly during the course of radiation therapy

次要结局

  • To study the time of onset & duration for healing of grade III & IV oral mucositis.(Weekly during the course of radiation therapy)

研究者

发起方
VMMC and Safdarjung hospital
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

DEVAL GUPTA

VMMC AND Safdarjung hospital

研究点 (1)

Loading locations...

相似试验